Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum BioVaxys Technology Corp. C.BIOV

Alternate Symbol(s):  BVAXF

BioVaxys Technology Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on improving patient lives with novel immunotherapies based on the DPX immune-educating technology platform and its HapTenix neoantigen tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization and other immunological fields. The Company's clinical... see more

CSE:BIOV - Post Discussion

BioVaxys Technology Corp. > $BIOV Seeking Alpha
View:
Post by ChaseAckland on Jan 06, 2021 7:08pm

$BIOV Seeking Alpha

Just saw this tonight...

https://seekingalpha.com/instablog/49795690-rashis-chakma/5540127-biovaxys-vaccine-breakthrough
Comment by radiomann11 on Jan 07, 2021 9:21am
Article from ywsterday. Good find https://seekingalpha.com/instablog/49795690-rashis-chakma/5540127-biovaxys-vaccine-breakthrough
Comment by ChaseAckland on Jan 07, 2021 10:22am
Ovarian cancer has significant unmet treatment needs---good disease target for oncology companies w/ new approaches.  Mostly asymptomatic in early stages (STage 1 and 2) , so majority of cases are diagnosed with stage III and stage IV disease, w/ stage III / stage IV oc ultimately being recurrent & resistant to chemo.   If you do some desk research you see a median ...more  
BioVaxys Technology Corp.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities